IMOVAX d.T., SUSPENSION FOR INJECTION IN 0.5 mL PRE-FILLED SYRINGE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSANOFI-AVENTIS SINGAPORE PTE. LTD.

Product Classification

Drug Type

Therapeutic

Forensic Class

Prescription Only

HSA Singapore Classification

Formulation Information

Dosage Form

INJECTION, SUSPENSION

Route of Administration

INTRAMUSCULAR

Medical Information

ATC Code

J07AM51

Manufacturer Information

Pharmaceutical Manufacturer

SANOFI-AVENTIS SINGAPORE PTE. LTD.

Manufacturers

Sanofi Pasteur (VDR)

Active Ingredients

Ingredient Name

Purified Tetanus Toxoid

Strength

≥ 20 IU/ 0.5mL

Drug MonographClostridium tetani toxoid antigen (formaldehyde inactivated)

Ingredient Name

Purified Diphtheria Toxoid

Strength

≥ 2 IU/ 0.5 mL

Drug MonographNeisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen

Documents

Package Inserts

Imovax dT PI final April 2024.pdf

Approved: April 30, 2024

Download

AI-Powered Research

Premium Access

Regulatory Information

Regulatory Responsibility

Product Classification

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

Documents

Package Inserts

MedPath

Product

Company

Legal